Towards (cost)effective cardiovascular risk management: using new drugs vs. the better use of available ones

Int J Clin Pract. 2010 Jan;64(2):138-40. doi: 10.1111/j.1742-1241.2009.02233.x.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Cardiovascular Agents / economics
  • Cardiovascular Agents / supply & distribution
  • Cardiovascular Agents / therapeutic use*
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / economics
  • Cost-Benefit Analysis
  • Humans

Substances

  • Cardiovascular Agents